MEDS
Trxade Group
MEDS45
$7.03arrow_drop_down0.14%-$0.01
MEDS
MEDS45
$7.03
arrow_drop_down0.14%Performance History
| Key Stats | |
|---|---|
| Open | $7.29 |
| Prev. Close | $7.04 |
| EPS | -24.38 |
| Dividend | - |
| Next Earnings Date | - |
| Dividend Yield % | - |
| Market Cap | $13.28M |
| PE Ratio | - |
| LOW | HIGH | |
|---|---|---|
| Day Range | 7.00 | 7.34 |
| 52 Week Range | 3.69 | 44.56 |
| Ratios | |
|---|---|
| EPS | -24.38 |
Score Breakdown
Welcome to Stocklytics
Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.
Analyst Forecast
Period: Next 12 Months
•Analyst Ratings
••
About Trxade Group (MEDS)
- Sector
- Healthcare
- Industry
- Pharmaceutical Retailers
- CEO
- Mr. Surendra K. Ajjarapu
- Headquarters
- Lutz
- Employees
- 33
- Exchange
- NASDAQ
Keep an eye on Trxade Group
Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
Frequently Asked Questions
help
What is Trxade Group 's (MEDS) price per share?
The current price per share for Trxade Group (MEDS) is $7.03. The stock has seen a price change of -$0.01 recently, indicating a -0.14% change. This reflects the stock's recent market performance and investor sentiment.
help
What is the 52-week high and low for Trxade Group (MEDS)?
For Trxade Group (MEDS), the 52-week high is $44.56, which is 533.85% from the current price. The 52-week low is $3.69, the current price is 90.51% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.
help
Is Trxade Group (MEDS) a growth stock?
Trxade Group (MEDS) has shown an average price growth of -5.34% over the past three years. It has received a score of 20 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Trxade Group as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.
help
What is Trxade Group (MEDS) stock price performance year to date (YTD)?
As of the latest data, Trxade Group (MEDS) has a year-to-date price change of 31.4%. Over the past six months, the figure is -16.51%.
help
Is Trxade Group (MEDS) a profitable company?
Trxade Group (MEDS) has a net income of -$13.72M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 31.41% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -8K% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $8.27M, although specific revenue growth data is currently not available. The gross profit is $2.6M. Operating income is noted at -$7.26M. Furthermore, the EBITDA is -$12.04M.
help
What is the market capitalization of Trxade Group (MEDS)?
Trxade Group (MEDS) has a market capitalization of $13.28M. The average daily trading volume is 12.66K, indicating the stock's liquidity and investor engagement.